Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sunshine Biopharma Inc SBFM

Healthcare Biotechnology
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid... see more

Recent & Breaking News (NDAQ:SBFM)

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

ACCESS Newswire 10 days ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

ACCESS Newswire May 15, 2025

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

ACCESS Newswire May 6, 2025

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

ACCESS Newswire April 21, 2025

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

ACCESS Newswire April 3, 2025

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

ACCESS Newswire April 2, 2025

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

ACCESS Newswire April 2, 2025

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

ACCESS Newswire April 1, 2025

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

ACCESS Newswire March 24, 2025

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

ACCESS Newswire March 10, 2025

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

ACCESS Newswire January 21, 2025

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

ACCESS Newswire January 15, 2025

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

ACCESS Newswire December 9, 2024

Sunshine Biopharma Launches a New Generic Prescription Drug

ACCESS Newswire December 4, 2024

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

ACCESS Newswire December 2, 2024

Sunshine Biopharma Launches a New Generic Prescription Drug

ACCESS Newswire November 22, 2024

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

ACCESS Newswire November 6, 2024

Sunshine Biopharma Launches Two New Generic Prescription Drugs

ACCESS Newswire September 26, 2024

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

ACCESS Newswire September 4, 2024

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

ACCESS Newswire August 26, 2024